0001181431-14-032520.txt : 20140923
0001181431-14-032520.hdr.sgml : 20140923
20140923132106
ACCESSION NUMBER: 0001181431-14-032520
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140919
FILED AS OF DATE: 20140923
DATE AS OF CHANGE: 20140923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAUWENBERGH GEERT
CENTRAL INDEX KEY: 0001285648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 141115649
MAIL ADDRESS:
STREET 1: 1 STULTS DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
4
1
rrd416570.xml
PRIMARY DOCUMENT
X0306
4
2014-09-19
0
0001533040
RXi Pharmaceuticals Corp
RXII
0001285648
CAUWENBERGH GEERT
C/O RXI PHARMACEUTICALS CORPORATION
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
1
1
0
0
President & CEO
Common stock, $0.0001
2014-09-19
4
P
0
4500
2.20
A
4500
I
By child
Common stock, $0.0001
41000
D
Common stock, $0.0001
5000
I
By spouse
Represents shares held by the Reporting Person's son. The Reporting Person disclaims beneficial ownership of such shares and this report shall not constitute an admission of beneficial ownership.
Caitlin Kontulis, attorney-in-fact
2014-09-23